Highlight
– In a secondary analysis of the PENUT randomized trial, AKI in extremely preterm infants (24–27 weeks’ gestation) was associated with higher adjusted odds of death or moderate to severe neurodevelopmental impairment at 22–26 months’ corrected age (AOR 1.53; 95% CI 1.07–2.18).
– Survivors with AKI had nearly doubled odds of cognitive delay (BSID-III cognitive score <85; AOR 1.94; 95% CI 1.25–2.99).
